Sotabase

Career

· PhD Student, University of Washington2018–
· Chief Registrar and Director of Conservation, American Museum of Natural History2011–
· Director of Conservation, Natural Science Collections, American Museum of Natural History2001–2011
· Associate Conservator, Anthropology, American Museum of Natural History1993–2001

Publications (18)

Drug-Induced Perturbations of the Bile Acid Pool, Cholestasis, and Hepatotoxicity: Mechanistic Considerations beyond the Direct Inhibition of the Bile Salt Export Pump
Drug Metabolism And Disposition · 2014
95
cited
Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain*
Journal of Biological Chemistry · 2015
82
cited
Inhibitor scaffolds as new allele specific kinase substrates.
Journal of the American Chemical Society · 2002
58
cited
Identification and optimization of a novel series of indoleamine 2,3-dioxygenase inhibitors.
Bioorganic & Medicinal Chemistry Letters · 2017
26
cited
Axonal myosins
Journal of Neurocytology · 2000
15
cited
Drug-Induced Perturbations of the Bile Acid Pool , Cholestasis , and Hepatotoxicity : Mechanistic Considerations Beyond the Direct Inhibition of the Bile Salt Export Pump
2013
12
cited
Challenges and Opportunities in Enabling High-Throughput, Miniaturized High Content Screening.
Methods in molecular biology · 2018
11
cited
Just-in-Time Compound Pooling Increases Primary Screening Capacity without Compromising Screening Quality
Journal of biomolecular screening · 2015
11
cited
Application of an in vitro OAT assay in drug design and optimization of renal clearance
Xenobiotica; the fate of foreign compounds in biological systems · 2014
8
cited
Development of an LC-MS/MS method for high throughput quantification of metformin uptake in transporter inhibition assays.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2014
8
cited
Abstract B11: Preclinical and preliminary phase 1 trial results of JI‐101: A novel, oral tyrosine kinase inhibitor that selectively targets VEGFR2, EphB4, and PDGFR
2009
6
cited
Imidazo[1,2-a]pyrazine diaryl ureas: inhibitors of the receptor tyrosine kinase EphB4.
Bioorganic & Medicinal Chemistry Letters · 2009
5
cited
Abstract 17: Preclinical and phase 1 trial results of JI-101, a novel, oral tyrosine kinase inhibitor that selectively targets VEGFR2, EphB4, and PDGFRβ
2010
3
cited
Convex relaxation for finding planted influential nodes in a social network
arXiv.org · 2013
3
cited
Development of a high-throughput mass spectrometry based analytical method to support an in vitro OATP1B1 inhibition screening assay.
Rapid Communications in Mass Spectrometry · 2016
2
cited
39 Discovery and development of multiplex angiogenesis inhibitors that target EphB4: validation with a novel chemical-genetics based in vivo model
2004
DMD054205 566..574
2014
Rebels with a Cause: A Survey of Terrorism in Chechnya and Important Lessons the Chechen Crisis Presents for the United States
2013
Sotabase
Lisa Elkin | Researcher Profile | Sotabase | Sotabase